Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
VK-2735 by Viking Therapeutics for Obesity: Likelihood of Approval
VK-2735 is under clinical development by Viking Therapeutics and currently in Phase II for Obesity. According to GlobalData, Phase II...
Data Insights
VK-2735 by Viking Therapeutics for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
VK-2735 is under clinical development by Viking Therapeutics and currently in Phase I for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...